Gholamreza Toogeh, Hassan Abolghasemi, Peyman Eshghi, Mohammadreza Managhchi, Mohammadreza Shaverdi-niasari, Katayoon Karimi, . . . Alireza Abdollahi. (2016). Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology.
Chicago Style (17th ed.) CitationGholamreza Toogeh, Hassan Abolghasemi, Peyman Eshghi, Mohammadreza Managhchi, Mohammadreza Shaverdi-niasari, Katayoon Karimi, Samin Roostaei, Neda Emran, and Alireza Abdollahi. Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology, 2016.
MLA (9th ed.) CitationGholamreza Toogeh, et al. Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study). Iranian Society of Pathology, 2016.